Are there any estimates about releasing this technology for general use? Or does the (US) FDA insist on slowing down this type of diagnostic technology a few decades, or can we expect to see these as kiosks in every clinic over the next few months?
You don't seem to understand the actual problems with screening. Try learning about the field before implying the FDA isn't doing their job: https://www.bmj.com/content/352/bmj.h6080
at the moment they are essentially saying it's a promising tech that helps experts and cuts down on their errors. It helps with one part of the analysis. Looks like it is a long way from anything general use, though it's on the path towards that.
